NEW YORK (AP) _ Oramed Pharmaceuticals Inc. (ORMP) on Thursday reported a loss of $2.5 million in its fiscal first quarter.
On a per-share basis, the New York-based company said it had a loss of 15 cents.
The drug maker posted revenue of $674,000 in the period.
Oramed shares have risen nearly 7% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.50, an increase of 59% in the last 12 months.